WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Autoneuron
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, May 10, 2006, 26(19):5180-5189; doi:10.1523/JNEUROSCI.0739-06.2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stutzmann, G. E.
Right arrow Articles by Parker, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stutzmann, G. E.
Right arrow Articles by Parker, I.

 Previous Article  |  Next Article 

Neurobiology of Disease
Enhanced Ryanodine Receptor Recruitment Contributes to Ca2+ Disruptions in Young, Adult, and Aged Alzheimer's Disease Mice

Grace E. Stutzmann, Ian Smith, Antonella Caccamo, Salvatore Oddo, Frank M. LaFerla, and Ian Parker

Department of Neurobiology and Behavior, University of California, Irvine, Irvine, California 92697-4550

Correspondence should be addressed to Grace E. Stutzmann, Rosalind Franklin University of Medicine and Science, The Chicago Medical School, 3333 Green Bay Road, North Chicago, IL 60064. Email: grace.stutzmann{at}rosalindfranklin.edu

Neuronal Ca2+ signaling through inositol triphosphate receptors (IP3R) and ryanodine receptors (RyRs) must be tightly regulated to maintain cell viability, both acutely and over a lifetime. Exaggerated intracellular Ca2+ levels have been associated with expression of Alzheimer's disease (AD) mutations in young mice, but little is known of Ca2+ dysregulations during normal and pathological aging processes. Here, we used electrophysiological recordings with two-photon imaging to study Ca2+ signaling in nontransgenic (NonTg) and several AD mouse models (PS1KI, 3xTg-AD, and APPSweTauP301L) at young (6 week), adult (6 months), and old (18 months) ages. At all ages, the PS1KI and 3xTg-AD mice displayed exaggerated endoplasmic reticulum (ER) Ca2+ signals relative to NonTg mice. The PS1 mutation was the predominant "calciopathic" factor, because responses in 3xTg-AD mice were similar to PS1KI mice, and APPSweTauP301L mice were not different from controls. In addition, we uncovered powerful signaling interactions and differences between IP3R- and RyR-mediated Ca2+ components in NonTg and AD mice. In NonTg mice, RyR contributed modestly to IP3-evoked Ca2+, whereas the exaggerated signals in 3xTg-AD and PS1KI mice resulted primarily from enhanced RyR-Ca2+ release and were associated with increased RyR expression across all ages. Moreover, IP3-evoked membrane hyperpolarizations in AD mice were even greater than expected from exaggerated Ca2+ signals, suggesting increased coupling efficiency between cytosolic [Ca2+] and K+ channel regulation. We conclude that lifelong ER Ca2+ disruptions in AD are related to a modulation of RyR signaling associated with PS1 mutations and represent a discrete "calciumopathy," not merely an acceleration of normal aging.

Key words: Alzheimer; ryanodine receptor; calcium [Ca]; cortex; imaging; inositol trisphosphate; age; presenilin; beta-amyloid


Received Dec. 12, 2005; revised March 27, 2006; accepted March 30, 2006.

Correspondence should be addressed to Grace E. Stutzmann, Rosalind Franklin University of Medicine and Science, The Chicago Medical School, 3333 Green Bay Road, North Chicago, IL 60064. Email: grace.stutzmann{at}rosalindfranklin.edu




This article has been cited by other articles:


Home page
Learn. Mem.Home page
N. Galeotti, A. Quattrone, E. Vivoli, M. Norcini, A. Bartolini, and C. Ghelardini
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes
Learn. Mem., April 25, 2008; 15(5): 315 - 323.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
G. E. Stutzmann
The Pathogenesis of Alzheimers Disease Is It a Lifelong "Calciumopathy"?
Neuroscientist, October 1, 2007; 13(5): 546 - 559.
[Abstract] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G. E STUTZMANN, I. SMITH, A. CACCAMO, S. ODDO, I. PARKER, and F. LAFERLA
Enhanced Ryanodine-Mediated Calcium Release in Mutant PS1-Expressing Alzheimer's Mouse Models
Ann. N.Y. Acad. Sci., February 1, 2007; 1097(1): 265 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Supnet, J. Grant, H. Kong, D. Westaway, and M. Mayne
Amyloid-beta-(1-42) Increases Ryanodine Receptor-3 Expression and Function in Neurons of TgCRND8 Mice
J. Biol. Chem., December 15, 2006; 281(50): 38440 - 38447.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-